Naltrexone for Individuals of East Asian Descent
Public ClinicalTrials.gov record NCT02026011. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Optimizing Naltrexone for Individuals of East Asian Descent
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will elucidate the pharmacogenetic effects of the Asn40Asp SNP of the OPRM1 gene on biobehavioral and neural markers of response to naltrexone in individuals of East Asian descent, an ethnic group most likely to express the positive predictive allele.
Study identification
- NCT ID
- NCT02026011
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2013
- Primary completion
- Aug 31, 2016
- Completion
- Aug 31, 2016
- Last update posted
- Jul 16, 2019
2013 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Addictions Laboratory | Los Angeles | California | 90095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Alcohol Use Disorder trials
Other public records listing Alcohol Use Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT05607290: Clinical Course of Alcohol Use Disorder Recovery Active, not recruiting
- NCT07724275: Understanding Pathways to Wellness and Recovery in Detroit - Digital Recovery Support Services Recruiting
- NCT07678567: Pomegranate Dietary Supplements in AUD and ALD Not yet recruiting
- NCT05827159: Emergency Department-Initiated Medications for Alcohol Use Disorder Recruiting
- NCT07713251: Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training Recruiting
- NCT07701928: Daridorexant for People With Insomnia and Alcohol Use Disorder Study Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02026011, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2019 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02026011 live on ClinicalTrials.gov.